System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Epublish 5 citations

PubMed: 39896801 DOI: 10.3389/fimmu.2024.1471511

Aspartate aminotransferase to platelet ratio correlates with poor prognosis and metabolic alterations in infection.

Front Immunol 15:1471511

Authors: Chunxia Guo, Ruixue Li, Xia Wang, Xiulan Peng

Affiliations

  • Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Department of Internal Medicine, The Hospital of Wuhan University, Wuhan, Hubei, China.
  • Department of Pharmacy, The Second Affiliated Hospital of Jianghan University, Wuhan, Hubei, China.
  • Department of Oncology, The Second Affiliated Hospital of Jianghan University, Wuhan, Hubei, China.

Abstract

Introduction

Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease with a high mortality rate caused by . The aspartate aminotransferase to platelet ratio index (APRI) is a biomarker of liver injury and inflammation. This study aimed to examine the correlation between APRI and SFTS prognosis using clinical data analysis and attempt to explain its prognostic significance through metabolic analysis.

Methods

Data from hospitalized patients with a confirmed diagnosis of SFTS virus infection at Wuhan Union Hospital were retrospectively collected. The low and high APRI groups were 1:1 matched using propensity score matching (PSM) analysis. Fresh plasma was collected from patients with SFTS on admission and used for metabolic tests.

Results

A total of 617 patients with SFTS who met the inclusion criteria were selected for analysis. Survival analysis revealed that patients with SFTS with high APRI (> 35.3) had a substantially higher death rate than those with low APRI (≤ 35.3). Receiver operating characteristic analysis showed the predictive performance of APRI for SFTS prognosis is 0.77, with a 95% CI of 0.73-0.80, which was superior to NLR (area under the curve (AUC): 0.65), platelet-to-lymphocyte ratio (AUC: 0.54), and systemic immune-inflammation index (AUC: 0.58). The prognostic value and predictive performance of APRI were more substantial after PSM than before PSM. Metabolomic testing identified several differential serum metabolites, with alanine, aspartate, glutamate, glycerophospholipid, and tryptophan metabolism being the most important metabolic pathways.

Conclusion

A high APRI score was associated with relatively higher mortality in patients with SFTS, and its predictive performance for the survival outcome of SFTS was superior to that of well-recognized inflammatory scores. Alanine, aspartate, and glutamate metabolism are involved in the progression of SFTS.

MeSH

Mortality, Severe Fever With Thrombocytopenia Syndrome, Aspartate Aminotransferases, Survival Analysis, Transaminases, Immune System Diseases, Blood Platelets, Data Analysis, Prognosis, Infections